Declining pertussis incidence in Sweden following the introduction of acellular pertussis vaccine

By Olin P.   Gustafsson L.   Barreto L.   Hessel L.   Mast T.C.   Rie A.V.   Bogaerts H.   Storsaeter J.  

Vaccine, Vol. 21, Iss. 17, 2003-05 ,pp. : 2024-2030

Elsevier

Access to resources Recommend Favorite

An acellular pertussis vaccine in healthy adults: safety and immunogenicity

By Rothstein E.P.   Anderson E.L.   Decker M.D.   Poland G.A.   Reisinger K.S.   Blatter M.M.   Jacobson R.M.   Mink C.M.   Gennevois D.   Izu A.E.   Sinangil F.   Langenberg A.G.M.  

Vaccine, Vol. 17, Iss. 23, 1999-08 ,pp. : 2999-3006

Elsevier

Access to resources Recommend Favorite

Effects of pertussis vaccination on transmission: vaccine efficacy for infectiousness

By Preziosi M.-P.   Halloran M.E.  

Vaccine, Vol. 21, Iss. 17, 2003-05 ,pp. : 1853-1861

Elsevier

Access to resources Recommend Favorite

The effect of pertussis toxin and whole-cell pertussis vaccine on haemodynamics and autonomic responsiveness in the rat depends on route of administration and age

By van Amsterdam J.G.C.   te Biesebeek J.-D.   van de Kuil T.   van der Laan J.-W.   Wemer J.   de Wildt D.J.   Vleeming W.  

Vaccine, Vol. 16, Iss. 7, 1998-04 ,pp. : 666-671

Elsevier

Access to resources Recommend Favorite

The efficacy of a whole cell pertussis vaccine and fimbriae against Bordetella pertussis and Bordetella parapertussis infections in respiratory mouse model

By Heininger U.   Stehr K.   Cherry J.D.  

Vaccine, Vol. 16, Iss. 13, 1998-08 ,pp. : 1255-1255

Elsevier

Access to resources Recommend Favorite